Cell Therapy Manufacturing Center

Cell Therapy Manufacturing Center (CTMC) is a joint venture between MD Anderson Cancer Center and Resilience, established to accelerate the development and manufacturing of innovative cell therapies. Located in Houston, Texas, CTMC operates a 60,000-square-foot facility dedicated to process development and GMP manufacturing. The organization specializes in transitioning academic discoveries into clinical-grade products, focusing on modalities such as CAR-T, TCR-T, and TIL therapies. By leveraging MD Anderson's clinical expertise and Resilience's manufacturing technology, CTMC aims to reduce the time and cost of bringing cell-based immunotherapies to patients. The center serves as a strategic partner for both academic researchers and biotechnology companies seeking to advance their pipelines into clinical trials.